Lv2
130 积分 2024-02-04 加入
Molecular Mechanisms of Resistance to Cetuximab and Panitumumab in Colorectal Cancer
3天前
已完结
The natural product berberine synergizes with osimertinib preferentially against MET-amplified osimertinib-resistant lung cancer via direct MET inhibition
3个月前
已完结
Resistance mechanisms to targeted therapy in BRAF-mutant melanoma - A mini review
3个月前
已完结
Inhibition of hTERT/telomerase/telomere mediates therapeutic efficacy of osimertinib in EGFR mutant lung cancer
3个月前
已完结
Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology
4个月前
已完结
ALK positively regulates MYCN activity through repression of HBP1 expression
4个月前
已完结
Ceritinib in paediatric patients with anaplastic lymphoma kinase-positive malignancies: an open-label, multicentre, phase 1, dose-escalation and dose-expansion study
4个月前
已完结
Phase 1 study of ceritinib in pediatric patients with malignancies harboring activated anaplastic lymphoma kinase (ALK): Safety, pharmacokinetics and efficacy results from the fed population
4个月前
已完结
Burkitt lymphoma
7个月前
已完结
Taxanes: Microtubule and Centrosome Targets, and Cell Cycle Dependent Mechanisms of Action
7个月前
已完结
皖公网安备34019202002308
